000 02218 a2200649 4500
005 20250516204916.0
264 0 _c20150122
008 201501s 0 0 eng d
022 _a1097-6787
024 7 _a10.1016/j.jaad.2014.01.897
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrupashankar, D S
245 0 0 _aEfficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cSep 2014
300 _a484-92 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aChronic Disease
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIntention to Treat Analysis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aDogra, Sunil
700 1 _aKura, Mahendra
700 1 _aSaraswat, Abir
700 1 _aBudamakuntla, Leelavathy
700 1 _aSumathy, T K
700 1 _aShah, Radha
700 1 _aGopal, M G
700 1 _aNarayana Rao, T
700 1 _aSrinivas, C R
700 1 _aBhat, Ramesh
700 1 _aShetty, Narendra
700 1 _aManmohan, G
700 1 _aSai Krishna, Kotla
700 1 _aPadmaja, Dalavoi
700 1 _aPratap, Dasiga Venkata Subrahmanya
700 1 _aGarg, Vijay
700 1 _aGupta, Sandesh
700 1 _aPandey, Neeraj
700 1 _aKhopkar, Uday
700 1 _aMontero, Enrique
700 1 _aRamakrishnan, M S
700 1 _aNair, Pradip
700 1 _aGanapathi, Prasanna C
773 0 _tJournal of the American Academy of Dermatology
_gvol. 71
_gno. 3
_gp. 484-92
856 4 0 _uhttps://doi.org/10.1016/j.jaad.2014.01.897
_zAvailable from publisher's website
999 _c23709895
_d23709895